FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

716125002: Pembrolizumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3304810011 Pembrolizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3304811010 Pembrolizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3304810011 Pembrolizumab (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3304810011 Pembrolizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3304811010 Pembrolizumab en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3304811010 Pembrolizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
55781000195113 pembrolizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
70861000195116 Pembrolizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
831751000172113 pembrolizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
831751000172113 pembrolizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
55781000195113 pembrolizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
70861000195116 Pembrolizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pembrolizumab Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Pembrolizumab Is a agent d'anticorps monoclonal false Inferred relationship Existential restriction modifier (core metadata concept)
Pembrolizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Pembrolizumab Is a Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Pembrolizumab Has disposition Programmed cell death protein 1 inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Pembrolizumab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pembrolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Pembrolizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pembrolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Pembrolizumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pembrolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only pembrolizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pembrolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Pembrolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Pembrolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Pembrolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Pembrolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start